Foreign Litigation Funding Bill: Chamber Coalition Presses House Floor Vote on H.R. 2675
A U.S. Chamber-led coalition wrote to the House on November 12 urging passage of H.R. 2675, the foreign litigation funding bill that would force disclosure of foreign funders and ban foreign-government money. It has waited on the floor since June, with seven weeks left in the Congress.
Policy Desk··13 min read

The coalition push, and why it lands now
A coalition led by the U.S. Chamber of Commerce asked the House on November 12, 2026 to pass H.R. 2675, the Protecting Our Courts from Foreign Manipulation Act, a foreign litigation funding bill that would force disclosure of foreign money behind federal lawsuits and outlaw funding from foreign governments and sovereign wealth funds. The bill cleared the House Judiciary Committee 15-11 a year ago and has sat on the floor calendar since June 15, 2026, so the letter is a bid to move it during the post-election session before the 119th Congress expires on January 3, 2027.
The Chamber announced the letter on November 13 and describes the signers as a coalition of nearly 200 trade associations, state and local chambers and other groups from almost every state. Law360, reporting the same day, described the signers as dozens of local Chamber affiliates and large corporations. The figure is the Chamber's own count. Either way, the letter is the most visible push yet to get the foreign litigation funding bill a floor vote. It adds to a fall campaign that already includes a 214-company letter to the federal rules committee in September and Senate Judiciary Chairman Chuck Grassley's October request for a public Rule 26 disclosure mandate.
For plaintiffs' firms that finance mass tort inventories with outside capital, the bill matters for its reach rather than its headline. It is aimed at hostile foreign governments, but its disclosure duty reaches any "foreign person" who funds federal civil litigation. Under its effective-date clause, that duty would also apply to cases already on file.
What is the Protecting Our Courts from Foreign Manipulation Act?
The Protecting Our Courts from Foreign Manipulation Act is a federal bill that would regulate Third-Party Litigation Funding from outside the United States by adding a new section 1660 to chapter 111 of title 28 of the U.S. Code. In the 119th Congress it is H.R. 2675 in the House, sponsored by Rep. Ben Cline (R-Va.), and S. 3180 in the Senate, sponsored by Sen. John Kennedy (R-La.).
The bill's long title states two purposes: to increase transparency and oversight of third-party funding by foreign persons, and to prohibit such funding by foreign states and sovereign wealth funds. Cline's office describes three working parts:
- Disclosure. Any foreign person or entity taking part in federal civil litigation as a third-party funder must be disclosed.
- Prohibition. Foreign governments and sovereign wealth funds may not fund litigation in which they are not parties.
- Reporting. The Justice Department's National Security Division must report to Congress on foreign litigation funding across the federal judiciary.
The concept is not new. Kennedy and then-Sen. Joe Manchin (D-W.Va.) introduced a 2023 version as S. 2805, with a House companion, H.R. 5488, from Rep. Mike Johnson before he became Speaker. That version never reached committee markup. The 2025-2026 House bill is the first to do so.
What would H.R. 2675 require litigants to disclose?
H.R. 2675 would require a party or its counsel in a federal civil action to disclose the name of any foreign person, foreign state or sovereign wealth fund that has agreed to provide money for the litigation, and to certify the disclosure under penalty of perjury. Congress.gov's bill summary and the CBO describe these disclosure and certification duties. Their scope depends on the definitions:
- Foreign person is defined by cross-reference to section 101 of the Foreign Intelligence Surveillance Act (50 U.S.C. 1801), with foreign states carved out and treated separately. FISA's definition is broad: it reaches non-U.S. persons and foreign entities generally, not only adversary governments.
- Foreign state and sovereign wealth fund are defined in the new section and form the category subject to the outright ban.
- Monetary support includes funding provided "directly or indirectly," the phrase critics say makes the disclosure duty hard to bound.
A policy summary of the bill describes disclosure of each funder's name, address and citizenship within 30 days of filing suit or signing the funding agreement, whichever is later. The same summary says the duty can apply when foreign money funds a portfolio of a law firm's cases rather than a single claim. The bill pairs the disclosure duty with a continuing obligation to supplement. A failure to disclose or supplement exposes the party to sanctions modeled on those in the Federal Rules of Civil Procedure.
The International Legal Finance Association (ILFA), the funders' trade group, reads the text more broadly. Its July 2026 commentary argues the bill would require production of the underlying funding agreements whenever a funder takes overseas capital, including money from private investors in allied countries. It also argues the bill would have the Justice Department compile identities of those investors. Those readings are advocacy, and the reported text should be checked against them. Still, the direction of the dispute is clear: proponents describe a national-security disclosure statute, and opponents describe a general disclosure regime for any fund with a non-U.S. investor.
Does H.R. 2675 ban foreign litigation funding?
H.R. 2675 would ban only one category of foreign litigation funding: money from a foreign state or a sovereign wealth fund. It would be unlawful for either to provide monetary support, directly or indirectly, to a civil action in which it is not a named party. It would also be unlawful for a party or counsel to accept that support. Private foreign investors, such as a European pension fund, a Gulf family office or a London-listed funder, would not be barred. Their participation would have to be disclosed.
The two-tier design matters for how litigation finance is structured. Some commercial funders raise capital from institutional investors, which can include sovereign wealth funds, often through blind-pool vehicles in which the funder, not the investor, picks the cases. The "directly or indirectly" wording leaves open whether a sovereign wealth fund's limited-partner stake in a general funding vehicle counts as funding every case the vehicle finances. Industry critics have flagged that tracing problem. The bill text found in public summaries does not resolve it with a de minimis threshold or a look-through rule.
Has the House voted on the foreign litigation funding bill?
The House has not voted on H.R. 2675. The bill was ordered reported by the Judiciary Committee on November 20, 2025, formally reported with House Report 119-700 on June 15, 2026, and has awaited floor action since; no floor vote had been scheduled as of November 14, 2026.
| Date | Event |
|---|---|
| September 14, 2023 | Kennedy and Manchin introduce the 2023 version (S. 2805); House companion H.R. 5488 follows |
| April 7, 2025 | Rep. Ben Cline introduces H.R. 2675; referred to House Judiciary |
| November 18, 2025 | Judiciary Committee markup begins |
| November 18, 2025 | Sen. Kennedy introduces S. 3180, referred to Senate Judiciary |
| November 20, 2025 | Committee adopts an amendment in the nature of a substitute and orders the bill reported, 15-11 |
| February 11, 2026 | Grassley introduces the broader Litigation Funding Transparency Act (S. 3826) |
| June 15, 2026 | H.R. 2675 reported to the House with H. Rept. 119-700 |
| November 12, 2026 | Chamber-led coalition letter urges a floor vote |
| November 13, 2026 | Chamber release; Law360 and IPWatchdog report the letter |
| January 3, 2027 | 119th Congress ends; unenacted bills die |
The calendar is the whole story. A House floor vote in the lame-duck weeks is plausible, because the bill is short and was reported more than five months ago. Enactment is harder. S. 3180 has not been marked up in the Senate Judiciary Committee, and the Senate would need floor time in a session that already has year-end spending work. If neither chamber finishes, the sponsors start over in the 120th Congress with new numbers, though a House-passed bill would give them a stronger starting position.
Who supports and who opposes H.R. 2675?
H.R. 2675 is backed by the U.S. Chamber of Commerce and its Institute for Legal Reform, state and local chambers, insurers and their trade groups, and free-market groups such as the R Street Institute. It is opposed by the litigation finance industry, led by ILFA, and by House Judiciary Democrats, who supplied all 11 votes against it in committee.
The supporters' case rests on national security. Rival governments, they argue, can use U.S. litigation to drain American companies, gain access to confidential material through discovery, or push strategic cases, all without the court or the defendant knowing who is paying. The Chamber's letter calls the bill commonsense and bipartisan. Rep. Eugene Vindman (D-Va.) is among the 26 cosponsors listed on Congress.gov. The American Property Casualty Insurance Association endorsed Kennedy's Senate version when it was introduced.
The opposition has two strands. ILFA has said it shares concerns about adversarial nations manipulating U.S. courts. It told Bloomberg Law that Cline's bill "has no limiting principle and targets all foreign financing." The Democratic critique, in the committee report's dissenting views, is sharper: it questions whether the foreign-threat rationale is the real goal. Rep. Sydney Kamlager-Dove (D-Calif.) said during the committee's consideration that the bill would "sanction witch hunts to nullify verdicts that were lawfully obtained." Opponents also argue that limiting the capital behind claims would hurt plaintiffs who cannot afford to litigate against large corporate defendants without outside money.
How the bill compares with the other funding-disclosure tracks
H.R. 2675 is the furthest along of the federal funding bills. Bloomberg Law has called it the most advanced of three federal efforts to regulate litigation finance. It is also the narrowest, because it addresses only foreign money.
| Feature | H.R. 2675 / S. 3180 | S. 3826 (Litigation Funding Transparency Act) | Rule 26 amendment track | Ohio H.B. 105 |
|---|---|---|---|---|
| Vehicle | Federal statute (28 U.S.C. § 1660) | Federal statute | Federal Rules of Civil Procedure | State statute (R.C. 1357) |
| Covered funding | Foreign persons; ban on foreign states and sovereign wealth funds | All commercial funders, with foreign status flagged | All third-party funders (as proposed) | Consumer and commercial funders; foreign-source ban |
| Covered cases | Federal civil actions | Class actions, MDLs, consolidations of 100+ cases | Federal civil actions | Ohio proceedings |
| Disclosure goes to | Court and parties, sworn | Court and parties | Parties (as proposed) | Parties and insurers |
| Status (Nov. 14, 2026) | Awaiting House floor; Senate in committee | In Senate committee, no markup | Under subcommittee study; earliest effect Dec. 1, 2029 | In force since Oct. 6, 2026 |
States have moved faster. Ohio's law, effective October 6, 2026, already bars foreign-government funding of claims in Ohio courts, and more than 20 states regulate litigation funding in some form. A federal statute would cover federal cases, including the large MDL dockets where state laws have the least reach.
Would the bill apply to lawsuits already pending?
The bill would apply to lawsuits already pending. CBO describes its amendments as applying to any civil action pending on, or filed after, the date of enactment. A firm whose existing federal docket is financed in part by foreign capital would have to identify and disclose those sources once the law took effect. Any funding from a foreign state or sovereign wealth fund would become unlawful to receive from that date.
The bill's retroactive reach is limited to procedure; it does not void judgments already entered. But it creates two practical problems for funded plaintiffs with pending cases. First, funders would have to trace their own investor base to tell counsel whether disclosure is triggered, which most funding agreements do not require today. Second, a firm that discovers sovereign wealth money several layers up in a funding vehicle would have to restructure or unwind the arrangement mid-case.
How would H.R. 2675 affect mass tort firms and MDLs?
H.R. 2675 would reach every Multidistrict Litigation (MDL) because MDL member cases are federal civil actions, so plaintiffs' firms whose mass tort inventories are financed with foreign capital would have to disclose those funders in each covered case. Portfolio loans and law-firm credit facilities are common financing structures in mass torts. Those are the arrangements the "directly or indirectly" language is most likely to catch.
The effect on MDL practice would come through several channels:
- Case-specific disclosure at scale. A disclosure duty that attaches to each civil action could require filings in thousands of member cases unless the transferee judge consolidates them into a single leadership-level disclosure through a case-management order.
- Settlement leverage. Defendants have long argued that funders influence holdouts. A sworn list of foreign funders would let defendants test that argument in cases like the paraquat MDL, where a judge ordered a firm to disclose its funding in October 2026 after most of its clients declined a settlement.
- Common benefit and fee structures. Disclosure would show who stands behind the firms that hold leadership roles and draw from a Common Benefit Fund, which could invite objections to leadership appointments.
- Capital costs. If sovereign wealth money leaves the asset class, the cost of capital for contingency practices may rise. That pressure would fall hardest on mid-size firms that depend on portfolio financing to carry inventories through multi-year bellwether schedules.
Does the foreign litigation funding bill apply to mass arbitration?
The foreign litigation funding bill would generally not apply to mass arbitration, because its disclosure duty and ban attach to civil actions in federal court under title 28, not to individual arbitrations administered by the American Arbitration Association (AAA), JAMS or other providers. Funding of a Mass Arbitration campaign before the AAA or JAMS would remain governed by the provider's rules and any disclosure the arbitration agreement requires.
The edges are less clear. A petition under the Federal Arbitration Act (FAA) to compel arbitration, enforce fee obligations or confirm an award in federal court is itself a civil action, and a funder that financed the claimants could arguably have to be disclosed at that stage. Funded mass arbitration campaigns often end up in federal court through fee-payment fights or motions to compel, so claimant firms that rely on foreign capital should not assume the arbitral forum fully insulates them.
What it means for practitioners
- Plaintiffs' mass tort firms. Firms with portfolio or credit-facility financing should know whether any capital in their structure originates outside the United States, including through limited partners. Because the bill applies to pending actions, that diligence would be needed on day one rather than at the next financing.
- Litigation funders. Funders with sovereign wealth or foreign-government limited partners face the hardest question: whether a passive LP interest is "indirect" monetary support. Fund documents and side letters may need look-through representations and a way to exclude sovereign capital from U.S. federal deals.
- Defendants and insurers. The bill would give defendants a sworn statutory disclosure in every federal case. That is more than Rule 26 provides now and more than most local rules require. Expect motions to enforce it early in MDLs if it passes.
- MDL judges. Transferee courts would need case-management orders to keep the disclosure duty from producing thousands of duplicative filings.
- Arbitration practitioners. Provider-administered mass arbitrations sit largely outside the bill. Court proceedings around them may not.
FAQ
What is H.R. 2675?
H.R. 2675 is the Protecting Our Courts from Foreign Manipulation Act, a House bill from Rep. Ben Cline that would require disclosure of foreign litigation funders in federal civil cases and ban funding from foreign governments and sovereign wealth funds.
When did the coalition urge the House to pass H.R. 2675?
The Chamber-led coalition letter is dated November 12, 2026, and the Chamber announced it on November 13, 2026, urging House leaders to bring the bill to the floor and pass it.
Has H.R. 2675 passed the House?
No. H.R. 2675 passed the House Judiciary Committee 15-11 on November 20, 2025 and was reported on June 15, 2026, but the full House had not voted as of November 14, 2026.
Does the bill ban all foreign litigation funding?
No. The bill bans only funding from foreign states and sovereign wealth funds; private foreign funders and investors would still be allowed, but they would have to be disclosed.
How much would H.R. 2675 cost?
The Congressional Budget Office estimates that implementing H.R. 2675 would cost less than $500,000 over 2026-2031 and that the bill would impose intergovernmental and private-sector mandates.
What happens if Congress does not act by January 3, 2027?
If H.R. 2675 and S. 3180 are not enacted before the 119th Congress ends on January 3, 2027, both bills expire and would have to be reintroduced in the 120th Congress.
Published for legal professionals. Analysis and summaries only — not legal advice, and no attorney-client relationship is created by use of this site.
Read next

Grassley Litigation Funding Disclosure Letter Asks Rules Committee for a Public Rule 26 Mandate
Senate Judiciary Chairman Chuck Grassley's October 21 letter, docketed as suggestion 26-CV-46, urges a public third-party litigation funding disclosure rule. It lands against a Federal Judicial Center study finding about one New Jersey disclosure per 1,000 civil cases.
Policy Desk · 15 min

Ohio's Litigation Funding Law Takes Effect 6 October With a Foreign-Funder Ban and AG Registration
The Ohio litigation funding law enacted as Sub. H.B. 105 becomes operative on 6 October 2026, creating Revised Code Chapter 1357, repealing R.C. 1349.55 and imposing the first state ban on foreign governments, corporations and investors backing US claims. Consumer funders get 90 more days to register.
Policy Desk · 15 min

214 Companies Push a Rule 26 Litigation Funding Disclosure Requirement Onto the October Agenda
A letter filed on 14 September 2026 asks the Advisory Committee on Civil Rules to draft a uniform Rule 26 litigation funding disclosure requirement. The committee takes it up on 21 October — and the rule, if written, cannot bind anyone before December 2029.
Policy Desk · 17 min